Bluejay Diagnostics
BJDX
Bluejay Diagnostics (BJDX) earnings history
Most recent quarter
- Fiscal period
- Q3 2023
- Period end
- Sep 30, 2023
- EPS actual
- −$3,328.00
- EPS estimate
- −$1,304.00
- EPS surprise
- −155.21%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Nov 9, 2023
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2023 | Nov 9, 2023 | −$1,304.00 | −$3,328.00 | −155.21% | $0.00 | SEC |
| Q2 2023 | Aug 14, 2023 | −$1,184.00 | −$4,400.00 | −271.62% | $0.00 | SEC |
| Q1 2023 | May 10, 2023 | −$1,920.00 | −$3,840.00 | −100.00% | $0.00 | SEC |
| Q4 2022 | Mar 20, 2023 | $1,280.00 | −$3,520.00 | −375.00% | $0.00 | SEC |
| Q3 2022 | Nov 8, 2022 | −$2,560.00 | −$4,800.00 | −87.50% | $0.00 | — |
| Q2 2022 | Jul 26, 2022 | −$2,560.00 | −$3,200.00 | −25.00% | $249,040.00 | — |
| Q1 2022 | Apr 20, 2022 | −$3,520.00 | −$3,200.00 | +9.09% | $0.00 | — |
| Q4 2021 | Mar 10, 2022 | $0.00 | −$2,880.00 | +0.00% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Bluejay Diagnostics (BJDX) last report earnings?
Bluejay Diagnostics last reported on Nov 9, 2023, covering fiscal Q3 2023.
Did BJDX beat earnings estimates?
No. Bluejay Diagnostics reported EPS of −$3,328.00 for Q3 2023 against a −$1,304.00 estimate — a 155.21% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.